Biolegend, 100310, PE/Cyanine5 anti-mouse CD3ε Antibody, 100μg

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Armenian Hamster
Immunogen: H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine5 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32, and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Application References(PubMed link indicates BioLegend citation): Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block) Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ) Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB) Payer E, et al. 1991. J. Immunol. 146:2536. (IF) Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD) Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ) Henrickson M, et al. 1995. Transplantation 60:828. (Deplete) Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete) Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete) Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block) Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ) Ko SY, et al. 2005. J. Immunol. 175:3309. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F) Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F) Wang W, et al. 2007. J. Immunol. 178:4885. (Activ) Xiao S, et al. 2007. J. Exp. Med. 204:1691. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Kenna TJ, et al. 2008. Blood 111:2091. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed Schulteis RD, et al. 2008. Blood 295:G273. PubMed Qi Q, et al. 2009. Blood 114:564. PubMed Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed Yan J, et al. 2014. Vaccine. 32:2833. PubMed Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations: Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed van Elsas MJ, et al. 2023. J Immunother Cancer. 11:. PubMed Saha S, et al. 2023. Sci Rep. 13:4609. PubMed Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed Liu W, et al. 2022. Stem Cells Int. 2022:1052166. PubMed Dölz M, et al. 2022. iScience. 25:105372. PubMed Huseni MA, et al. 2023. Cell Rep Med. 4:100878. PubMed Stravokefalou V, et al. 2023. Front Immunol. 13:1014802. PubMed Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed Mann M, et al. 2018. Cell Rep. 25:2992. PubMed Dave K et al. 2017. eLife. 6 pii: e23382. PubMed Yang C, et al. 2020. J Control Release. 326:324. PubMed Liu Y, et al. 2021. Haematologica. Online ahead of print. PubMed Enriquez AB, et al. 2022. iScience. 25:104305. PubMed Ciecko AE, et al. 2019. Cell Rep. 29:3073. PubMed Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed Li J, et al. 2020. Cancer Discov. . PubMed Enriquez AB, et al. 2022. iScience. 25:104305. PubMed Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed Nelson SA, et al. 2022. NPJ Vaccines. 7:124. PubMed Li J, et al. 2018. Immunity. 49:178. PubMed Imani J, et al. 2021. JCI Insight. 6:. PubMed Mansell E, et al. 2020. Cell Stem Cell. . PubMed Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed Koma T, et al. 2014. J Virol. 88:7178. PubMed Balkow S, et al. 2010. Blood. 116:1885. PubMed Li X, et al. 2009. PLoS One. 4:e6385. PubMed Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed Zhang H, et al. 2019. Mol Cell. 76:110. PubMed Nacson J, et al. 2020. Molecular Cell. 78(5):951-959. PubMed Naik A, et al. 2015. J Immunol. 194:790. PubMed Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed Kwok T, et al. 2022. Front Aging. 3:838943. PubMed Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed Lu YJ, et al. 2021. Cell Rep. 36:109696. PubMed Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Natale CA, et al. 2018. Elife. 7. PubMed Koide S, et al. 2022. iScience. 25:103603. PubMed Riggs JB, et al. 2021. Front Microbiol. 12:656979. PubMed Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed Peltzer N, et al. 2018. Nature. 557:112. PubMed Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
RRID: AB_312674 (BioLegend Cat. No. 100309) AB_312675 (BioLegend Cat. No. 100310)
Structure: Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution: Thymocytes (differentiation dependent), mature T cells, NK-T cells
Function: TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor: Peptide antigen/MHC-complex
Cell Type: NKT cells, T cells, Thymocytes, Tregs
Biology Area: Immunology
Molecular Family: CD Molecules, TCRs
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263.
Gene ID: 12501
UniProt: View information about CD3epsilon on UniProt.org
Clone: 145-2C11
Regulatory Status: RUO
Other Names: CD3ε, T3, CD3
Isotype: Armenian Hamster IgG